Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 20, 2007

Chromos and Pain Thearapeutics Okay Cell Line Engineering Agreement

  • Chromos Molecular Systems inked a cell line development deal with Pain Therapeutics. It will engineer cell lines specific for the expression of a Mab for Pain Therapeutics using the ACE System.

    Pain Therapeutics has the right to use the cell lines for scale up and manufacture of the Mab, following the cell line engineering phase of the agreement.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »